United States Belimumab Market Report 2016

November 2016 | 102 pages | ID: UF53AC8E622EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Belimumab

Revenue, means the sales value of Belimumab

This report studies sales (consumption) of Belimumab in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• GlaxoSmithKline
• Sandoz
• Celltrion
• Delenex Therapeutics
• Bionovis
• Fujifilm Kyowa Kirin Biologics
• AryoGen Biopharma
• MedImmune
• Tsumura

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Belimumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Belimumab Market Report 2016

1 BELIMUMAB OVERVIEW

1.1 Product Overview and Scope of Belimumab
1.2 Classification of Belimumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Belimumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Belimumab (2011-2021)
  1.4.1 United States Belimumab Sales and Growth Rate (2011-2021)
  1.4.2 United States Belimumab Revenue and Growth Rate (2011-2021)

2 UNITED STATES BELIMUMAB COMPETITION BY MANUFACTURERS

2.1 United States Belimumab Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Belimumab Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Belimumab Average Price by Manufactures (2015 and 2016)
2.4 Belimumab Market Competitive Situation and Trends
  2.4.1 Belimumab Market Concentration Rate
  2.4.2 Belimumab Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BELIMUMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Belimumab Sales and Market Share by Type (2011-2016)
3.2 United States Belimumab Revenue and Market Share by Type (2011-2016)
3.3 United States Belimumab Price by Type (2011-2016)
3.4 United States Belimumab Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BELIMUMAB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Belimumab Sales and Market Share by Application (2011-2016)
4.2 United States Belimumab Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BELIMUMAB MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Belimumab Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
  5.2.2 Belimumab Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GlaxoSmithKline Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sandoz
  5.3.2 Belimumab Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sandoz Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Celltrion
  5.4.2 Belimumab Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Celltrion Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Delenex Therapeutics
  5.5.2 Belimumab Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Delenex Therapeutics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Bionovis
  5.6.2 Belimumab Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Bionovis Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Fujifilm Kyowa Kirin Biologics
  5.7.2 Belimumab Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Fujifilm Kyowa Kirin Biologics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 AryoGen Biopharma
  5.8.2 Belimumab Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 AryoGen Biopharma Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 MedImmune
  5.9.2 Belimumab Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 MedImmune Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Tsumura
  5.10.2 Belimumab Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Tsumura Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 BELIMUMAB MANUFACTURING COST ANALYSIS

6.1 Belimumab Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Belimumab

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Belimumab Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Belimumab Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BELIMUMAB MARKET FORECAST (2016-2021)

10.1 United States Belimumab Sales, Revenue Forecast (2016-2021)
10.2 United States Belimumab Sales Forecast by Type (2016-2021)
10.3 United States Belimumab Sales Forecast by Application (2016-2021)
10.4 Belimumab Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Belimumab
Table Classification of Belimumab
Figure United States Sales Market Share of Belimumab by Type in 2015
Table Application of Belimumab
Figure United States Sales Market Share of Belimumab by Application in 2015
Figure United States Belimumab Sales and Growth Rate (2011-2021)
Figure United States Belimumab Revenue and Growth Rate (2011-2021)
Table United States Belimumab Sales of Key Manufacturers (2015 and 2016)
Table United States Belimumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Belimumab Sales Share by Manufacturers
Figure 2016 Belimumab Sales Share by Manufacturers
Table United States Belimumab Revenue by Manufacturers (2015 and 2016)
Table United States Belimumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Belimumab Revenue Share by Manufacturers
Table 2016 United States Belimumab Revenue Share by Manufacturers
Table United States Market Belimumab Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Belimumab Average Price of Key Manufacturers in 2015
Figure Belimumab Market Share of Top 3 Manufacturers
Figure Belimumab Market Share of Top 5 Manufacturers
Table United States Belimumab Sales by Type (2011-2016)
Table United States Belimumab Sales Share by Type (2011-2016)
Figure United States Belimumab Sales Market Share by Type in 2015
Table United States Belimumab Revenue and Market Share by Type (2011-2016)
Table United States Belimumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Belimumab by Type (2011-2016)
Table United States Belimumab Price by Type (2011-2016)
Figure United States Belimumab Sales Growth Rate by Type (2011-2016)
Table United States Belimumab Sales by Application (2011-2016)
Table United States Belimumab Sales Market Share by Application (2011-2016)
Figure United States Belimumab Sales Market Share by Application in 2015
Table United States Belimumab Sales Growth Rate by Application (2011-2016)
Figure United States Belimumab Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Belimumab Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Belimumab Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Belimumab Sales Market Share (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltrion Belimumab Sales Market Share (2011-2016)
Table Delenex Therapeutics Basic Information List
Table Delenex Therapeutics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Delenex Therapeutics Belimumab Sales Market Share (2011-2016)
Table Bionovis Basic Information List
Table Bionovis Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionovis Belimumab Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Belimumab Sales Market Share (2011-2016)
Table AryoGen Biopharma Basic Information List
Table AryoGen Biopharma Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table AryoGen Biopharma Belimumab Sales Market Share (2011-2016)
Table MedImmune Basic Information List
Table MedImmune Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table MedImmune Belimumab Sales Market Share (2011-2016)
Table Tsumura Basic Information List
Table Tsumura Belimumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tsumura Belimumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Belimumab
Figure Manufacturing Process Analysis of Belimumab
Figure Belimumab Industrial Chain Analysis
Table Raw Materials Sources of Belimumab Major Manufacturers in 2015
Table Major Buyers of Belimumab
Table Distributors/Traders List
Figure United States Belimumab Production and Growth Rate Forecast (2016-2021)
Figure United States Belimumab Revenue and Growth Rate Forecast (2016-2021)
Table United States Belimumab Production Forecast by Type (2016-2021)
Table United States Belimumab Consumption Forecast by Application (2016-2021)